Goal:
12 - Sorumlu Üretim ve Tüketim

Project Logo
Description
SORUMLU ÜRETİM VE TÜKETİM Sürdürülebilir üretim ve tüketim kalıplarını sağlamak: Ekonomik büyüme ve sürdürülebilir kalkınmayı başarmak için, malları ve kaynakları üretme ve tüketme biçimlerimizi değiştirmek suretiyle ekolojik ayak izimizi derhal azaltmamız gerekiyor. Dünya genelinde en büyük su tüketicisi tarımdır ve tarımsal sulama, insanların kullandığı tüm taze suyun yaklaşık %70’ini buluyor.

Filters

2013 - 20192
Reset filters

Settings

Start date: 2010 × End date: 2019 × Has files: true ×

Publication Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    PublicationOpen Access
    Anticholinesterase furocoumarins from Heracleum platytaenium, a species endemic species to Ida Mountains
    (2013-01-01) Dincel, DEMET; Hatipoglu, Seda Damla; GOREN, AHMET CEYHAN; Topcu, Gulacti; DİNCEL, DEMET; GÖREN, AHMET CEYHAN; TOPÇU, GÜLAÇTI
    The petroleum ether extract of Heracleum platytaenium afforded 8 furocoumarins (psoralen, bergapten, xanthotoxin, pimpinellin, isopimpinellin, sphondin, byakangelicin, and heraclenol) and the methanol extract of H. platytaenium gave only 1 glycosylated dihydrofurocoumarin, apterin. In addition, stigmasterol was also obtained from petroleum ether extract. Structure identification of the isolated compounds has been achieved by using spectroscopic methods, namely 1D and 2D NMR experiments and mass spectral analyses. The antioxidant activity of the extracts and pure compounds was investigated by 2 methods, including DPPH free radical scavenging activity and lipid peroxidation inhibitory activity by beta-carotene-linoleic acid assays. The anticholinesterase activity of petroleum ether and methanol extracts of the plant and the isolated furocoumarins was investigated against acetylcholinesterase and butyrylcholinesterase enzymes by the Ellman method in vitro.
  • Thumbnail Image
    PublicationOpen Access
    Increasing access to integrated ESKD care as part of universal health coverage
    (2019-04-01) Harris, David C. H.; DAVIES, Simon J.; Finkelstein, Fredric O.; JHA, Vivekanand; DONNER, Jo-Ann; ABRAHAM, Georgi; Bello, Aminu K.; CASKEY, Fergus J.; GARCIA GARCIA, Guillermo; HARDEN, Paul; KAZANCIOĞLU, RÜMEYZA TURAN; Hemmelgarn, Brenda; JOHNSON, David W.; LEVIN, Nathan W.; Luyckx, Valerie A.; MARTIN, Dominique E.; McCulloch, Mignon I.; MOOSA, Mohammed Rafique; O'Connell, Philip J.; Okpechi, Ikechi G.; PECOITS FILHO, Roberto; SHAH, Kamal D.; SOLA, Laura; Swanepoel, Charles; Tonelli, Marcello; TWAHIR, Ahmed; VAN BIESEN, Wim; VARGHESE, Cherian; Yang, Chih-Wei; ZUNIGA, Carlos; ABU ALFA, Ali K.; ALJUBORI, Harith M.; ALRUKHAIMI, Mona N.; ANDREOLI, Sharon P.; ASHUNTANTANG, Gloria; Bellorin-Font, Ezequiel; BERNIEH, Bassam; IBHAIS, Fuad M.; BLAKE, Peter G.; BROWN, Mark; BROWN, Edwina; BUNNAG, Sakarn; CHAN, Tak Mao; CHEN, Yuqing; CLAURE-DEL GRANADO, Rolando; CLAUS, Stefaan; COLLINS, Allan; COPPO, Rosanna; COUCHOUD, Cecile; CUETO-MANZANO, Alfonso; CULLIS, Brett; DOUTHAT, Walter; DREYER, Gavin; EIAM-ONG, Somchai; EKE, Felicia U.; Feehally, John; GHNAIMAT, Mohammad A.; LEONG, Bak; HASSAN, Mohamed H.; HOU, Fan Fan; JAGER, Kitty; KALANTAR-ZADEH, Kamyar; Levin, Adeera; LIEW, Adrian; McKnight, Marla; TADESSE, Yewondwassesn; Morton, Rachael L.; Muller, Elmi; Murtagh, Fliss E. M.; Naicker, Saraladevi; Nangaku, Masaomi; NIANG, Abdou; OBRADOR, Gregorio T.; OSSAREH, Shahrzad; Perl, Jeffrey; RAHMAN, Muhibur; RASHID, Harun Ur; RICHARDS, Marie; RONDEAU, Eric; SAHAY, Manisha; SALEH, Abdulkarim; SCHNEDITZ, Daniel; TCHOKHONELIDZE, Irma; TESAR, Vladimir; Trask, Michele; TUNGSANGA, Kriang; VACHHARAJANI, Tushar; WALKER, Rachael C.; WALKER, Robert; WERE, Anthony J. O.; YAO, Qiang; YEATES, Karen; YU, Xueqing; ZAKHAROVA, Elena; ZEMCHENKOV, Alexander; Turan Kazancıoğlu, Rümeyza; Zhao, Ming-Hui; KAZANCIOĞLU, RÜMEYZA
    The global nephrology community recognizes the need for a cohesive strategy to address the growing problem of end-stage kidney disease (ESKD). In March 2018, the International Society of Nephrology hosted a summit on integrated ESKD care, including 92 individuals from around the globe with diverse expertise and professional backgrounds. The attendees were from 41 countries, including 16 participants from 11 low- and lower-middle-income countries. The purpose was to develop a strategic plan to improve worldwide access to integrated ESKD care, by identifying and prioritizing key activities across 8 themes: (i) estimates of ESKD burden and treatment coverage, (ii) advocacy, (iii) education and training/workforce, (iv) financing/funding models, (v) ethics, (vi) dialysis, (vii) transplantation, and (viii) conservative care. Action plans with prioritized lists of goals, activities, and key deliverables, and an overarching performance framework were developed for each theme. Examples of these key deliverables include improved data availability, integration of core registry measures and analysis to inform development of health care policy; a framework for advocacy; improved and continued stakeholder engagement; improved workforce training; equitable, efficient, and cost-effective funding models; greater understanding and greater application of ethical principles in practice and policy; definition and application of standards for safe and sustainable dialysis treatment and a set of measurable quality parameters; and integration of dialysis, transplantation, and comprehensive conservative care as ESKD treatment options within the context of overall health priorities. Intended users of the action plans include clinicians, patients and their families, scientists, industry partners, government decision makers, and advocacy organizations. Implementation of this integrated and comprehensive plan is intended to improve quality and access to care and thereby reduce serious health-related suffering of adults and children affected by ESKD worldwide.